Baxter (NYSE:BAX) said today that it closed its $625 million acquisition of Claris Lifesciences‘ (BOM:533288) injectable drug biz. According to the deal, Baxter gains Claris’ portfolio of injectable generics and three manufacturing plants. The Deerfield, Ill.-based company said it plans to add new aseptic manufacturing and lyophilization capabilities, as well as invest in new technology platforms, including […]
Wall Street Beat
Spectranetics wins FDA nod for Stellarex DCB
Spectranetics (NSDQ:SPNC) said today that its Stellarex drug-coated balloon won FDA pre-market approval. The device is designed to treat patients with peripheral arterial disease, bringing blood flow back to the superficial femoral and popliteal arteries. Get the full story at our sister site, Drug Delivery Business News.
Smith & Nephew tops Q2 estimates
Smith & Nephew (NYSE:SNN) beat the consensus sales forecast with its second-quarter results with emerging markets gaining at a double-digit clip, sending share prices up in London and New York today. The British orthopedics and wound care company posted profits of $324 million, or 37¢ per share, on sales of $2.34 billion for the three […]
Boston Scientific swings to Q2 black
Boston Scientific (NYSE:BSX) swung to second-quarter black today, beating the consensus estimates on Wall Street for both sales and earnings and raising its outlook for the rest of the year. The Marlborough, Mass.-based medical device giant posted profits of $146 million, or 11¢ per share, on sales of $2.26 billion for the three months ended June […]
Edwards Lifesciences shares rise on Q2 earnings beat
Shares in Edwards Lifesciences (NYSE:EW) jumped in after-hours trading today after the medical device maker beat expectations on Wall Street with its 2nd quarter earnings results. The Irvine, Calif.-based company posted profits of $186.1 million, or 86¢ per share, on sales of $841.8 million for the 3 months ended June 30, for bottom-line growth of 47% […]
Invuity shares fall on Q2 earnings miss, lowered outlook
Shares in Invuity (NSDQ:IVTY) fell today after the medical device maker missed expectations on Wall Street with its 2nd quarter earnings results. The San Francisco, Calif.-based company posted losses of $10.4 million. or 61¢ per share, on sales of $9.8 million for the 3 months ended June 30, seeing losses grow 2.5% while sales grew 18.8% compared […]
Amgen shares fall after Q2 earnings reveal ‘bare’ pipeline
Shares in Amgen (NSDQ:AMGN) fell today even though the biotech topped expectations on Wall Street with its second quarter results. The Thousand Oaks, Calif.-based company posted profits of $2.2 million, or $2.91 per share, on sales of $5.8 billion for the 3 months ended June 30, for bottom-line growth of 15% on sales growth of 2% compared with […]
New GSK chief taps WalMart exec, refocuses R&D efforts
GlaxoSmithKline‘s (NYSE:GSK) has reportedly named former WalMart executive Karenann Terrell as chief digital and technology officer, in a move to integrate digital technology across its pharmaceutical business. This is among the many choices made by newly appointed chief executive Emma Walmsley to boost GSK’s ability to compete with rival pharma companies. GSK also recently nabbed […]
BioCardia treats 10-patient cohort in late-stage heart failure trial
BioCardia (NSDQ:BCDA) said today that it finished treating a 10-patient cohort in its pivotal Phase III CardiAmp heart failure trial. The company reported that it expects a review of the 30-day outcomes for this cohort in the third quarter of this year. Get the full story at our sister site, Drug Delivery Business News.
Sotera Wireless emerges from bankruptcy with $32m
Sotera Wireless emerged from bankruptcy protection with nearly $32 million in hand, after a lawsuit brought by rival Masimo (NSDQ:MASI) drained its coffers, but is enjoined from using Masimo data allegedly purloined by a pair of former employees who jumped ship for Sotera. The San Diego-based company filed for Chapter 11 bankruptcy protection in September 2016, saying it owed […]
Roche taps Accenture’s analytics tech for digital diabetes management
Accenture (NYSE:ACN) said today that it inked a five-year deal with Roche (OTC:RHHBY) to incorporate its analytics platform into Roche’s digital diabetes management system. According to the deal, Roche’s new digital “diabetes ecosystem” will be built on the Accenture Intelligent Patient Platform. The system reportedly allows Roche to collect and analyze data from diabetes patients in the […]